Luca Afferi (@luca_afferi) 's Twitter Profile
Luca Afferi

@luca_afferi

MD, MPH @HarvardChanSPH | Oberarzt i.V. @ksaaarau | Chairman @ESRUrology | Assoc @EAU_YAUrotheli | Prev Uroonc Fellow @FPuigvert & Resident @kantonsspitalLU

ID: 1015807705574006784

linkhttps://scholar.google.com/citations?user=J3FB7UAAAAAJ&hl=it calendar_today08-07-2018 04:00:04

806 Tweet

613 Followers

378 Following

Félix Guerrero-Ramos (@drfelixguerrero) 's Twitter Profile Photo

⚠️For the 1st time in almost 50 years something shows superiority to #BCG alone in HR-NMIBC 🔗 tinyurl.com/5n74kfv8 🍾Today makes history! 🧐Looking forward to the data in detail 🤩Happy to be part of this with my team Department of Urology, Hospital 12 De Octubre Cgdelcanizo Mario Hernández Arroyo Óscar Rodríguez Faba

⚠️For the 1st time in almost 50 years something shows superiority to #BCG alone in HR-NMIBC
🔗 tinyurl.com/5n74kfv8
🍾Today makes history!
🧐Looking forward to the data in detail
🤩Happy to be part of this with my team
<a href="/Urologia12/">Department of Urology, Hospital 12 De Octubre</a> <a href="/cgdelcanizo/">Cgdelcanizo</a> <a href="/MarioHArroyo/">Mario Hernández Arroyo</a> <a href="/RodriguezFaba/">Óscar Rodríguez Faba</a>
BURST Urology (@bursturology) 's Twitter Profile Photo

🤩 What a few days at #EAU25! 👏 A huge thank you to our international collaborators, YAU, ESRU, and all who joined us for the BURST session. 👀 We can’t wait to see you in London for #EAU26 — with new committee members joining the team! Until next time! #UroSoMe

🤩 What a few days at #EAU25!

👏 A huge thank you to our international collaborators, YAU, ESRU, and all who joined us for the BURST session.

👀 We can’t wait to see you in London for #EAU26 — with new committee members joining the team!

Until next time! #UroSoMe
Ashish M. Kamat, MD, MBBS (@urodocash) 's Twitter Profile Photo

Durvalumab with Gem Cis followed by adjuvant durvalumab after RC approved by U.S. FDA for MIBC based on #NIAGARA trial Congratulations to Tom Powles jim catto Matt Galsky Joshua Meeks et al fda.gov/drugs/resource…

European Society of Residents in Urology (@esrurology) 's Twitter Profile Photo

Big changes at ESRU! ✨ We’re saying goodbye to some incredible board members 👋❤️ and welcoming new faces ready to lead 🚀🌟 Grateful for the impact made, and excited for what’s ahead as we work to improve urology residency across Europe 🇪🇺 🤝🌍 #ESRU European Association of Urology (EAU) EAU Young Urologists

Big changes at ESRU! ✨
We’re saying goodbye to some incredible board members 👋❤️ and welcoming new faces ready to lead 🚀🌟
Grateful for the impact made, and excited for what’s ahead as we work to improve urology residency across Europe 🇪🇺 🤝🌍
#ESRU <a href="/Uroweb/">European Association of Urology (EAU)</a> <a href="/eau_yuo/">EAU Young Urologists</a>
Olivier Traxer (@otraxer) 's Twitter Profile Photo

BN153: STONE-SENSE by IPG Photonics AUA2025. Don’t miss 2 presentations about STONE-SENSE! Invented by IPG (Inventor of ThuliumFiberLaser).First time presented at a scientific meeting. Sat.26th Pr MARTOV:Initial Clinical experience & Monday28th Pr TRAXER: Pre-clinical Evaluation

UroToday.com (@urotoday) 's Twitter Profile Photo

Radical cystectomy vs bladder-sparing therapy for recurrent high-grade non-muscle invasive bladder cancer: Results from the comparison of intravesical therapy and surgery as treatment. The #CISTO study. Presented by John Gore, MD, MS, FACS University of Washington. #AUA25 written coverage by

Radical cystectomy vs bladder-sparing therapy for recurrent high-grade non-muscle invasive bladder cancer: Results from the comparison of intravesical therapy and surgery as treatment. The #CISTO study. Presented by John Gore, MD, MS, FACS <a href="/UW/">University of Washington</a>. #AUA25 written coverage by
Joshua Meeks (@joshmeeks) 's Twitter Profile Photo

A lot of talk about patients with borderline renal function (GFR of 40-60 ml/min) that are ? cis-eligible. Here, we present the outcomes of patients from Niagara, showing consistent improvement in EFS and pCR. #AUA2025

A lot of talk about patients with borderline renal function (GFR of 40-60 ml/min) that are ? cis-eligible. Here, we present the outcomes of patients from Niagara, showing consistent improvement in EFS and pCR. #AUA2025
Olivier Traxer (@otraxer) 's Twitter Profile Photo

BN154:For my friend Dr Mohamed Omar &unanswered question at AUA25.New STONE SENSE technology invented by IPGMedical.StoneS. time reaction is 2 to6 msecond vs Human time reaction 150 to250 msecond: 40 times faster!To prevent tissue damage. A must for Laser safety

BN154:For my friend Dr Mohamed Omar &amp;unanswered question at AUA25.New STONE SENSE technology invented by IPGMedical.StoneS. time reaction is 2 to6 msecond vs Human time reaction 150 to250 msecond: 40 times faster!To prevent tissue damage. A must for Laser safety
European Urology Oncology (@eururoloncol) 's Twitter Profile Photo

EUO PRIORITY ARTICLE – EDITORIAL: Lights and Shadows of Bacillus Calmette-Guérin (BCG)-exposed and BCG-unresponsive Definitions: A Practical Overview by Luca Afferi et al Read the full editorial here: euoncology.europeanurology.com/article/S2588-… #EUO #UroSoMe #MedTwitter #PriorityArticle

EUO PRIORITY ARTICLE – EDITORIAL: Lights and Shadows of Bacillus Calmette-Guérin (BCG)-exposed and BCG-unresponsive Definitions: A Practical Overview by Luca Afferi et al

Read the full editorial here: euoncology.europeanurology.com/article/S2588-… 

#EUO #UroSoMe #MedTwitter #PriorityArticle
Tom Powles (@tompowles1) 's Twitter Profile Photo

POTOMAC trial- Durvalumab + BCG shows positive results for DFS in high-risk NMIBC vs BCG alone. sasanlimab (CREST) also had an EFS advantage here: HR 0.68. Consistent results in early disease is compelling. IO tox is relevant in risk/benefit ratio. astrazeneca.com/media-centre/p…

POTOMAC trial- Durvalumab + BCG shows positive results for DFS in high-risk NMIBC vs BCG alone. sasanlimab (CREST) also had an EFS advantage here: HR 0.68. Consistent results in early disease is compelling. IO tox is relevant in risk/benefit ratio.   astrazeneca.com/media-centre/p…
EBU (@ebu_urology) 's Twitter Profile Photo

We are proud to present #ETR_Version2025, a revised document that outlines the essential areas of expertise to be achieved by #urology_trainees and #training_institutions. Scan the QR code to review the document and download your copy! #ebu #europeanboardofurology #urology

European Urology (@euplatinum) 's Twitter Profile Photo

SPOTLIGHT: Robot-assisted Kidney Transplantation: The 8-year European Experience by Luca Afferi, Angelo Territo et al. Read the full article: buff.ly/6HILUXn #UroSoMe #OrganTransplant #RoboticAssistedKidneyTransplantation #SurgicalInnovation #MedicalCommunity